Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats

Objective. Phosphatidylcholine (PC) is the major surface-active phospholipid and creates a hydrophobic nature to the surface. It has been reported to reverse the progression of liver fibrosis and to improve liver function. The aim of the present study was to evaluate the effects of orally administer...

Full description

Saved in:
Bibliographic Details
Main Authors: Meijuan Chen, Haijun Huang, Pengcheng Zhou, Jiajie Zhang, Yining Dai, Danhong Yang, Xuegong Fan, Hongying Pan
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/8723460
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568396099616768
author Meijuan Chen
Haijun Huang
Pengcheng Zhou
Jiajie Zhang
Yining Dai
Danhong Yang
Xuegong Fan
Hongying Pan
author_facet Meijuan Chen
Haijun Huang
Pengcheng Zhou
Jiajie Zhang
Yining Dai
Danhong Yang
Xuegong Fan
Hongying Pan
author_sort Meijuan Chen
collection DOAJ
description Objective. Phosphatidylcholine (PC) is the major surface-active phospholipid and creates a hydrophobic nature to the surface. It has been reported to reverse the progression of liver fibrosis and to improve liver function. The aim of the present study was to evaluate the effects of orally administered PC on intestinal barrier function (IBF) in rats with drug-induced liver injury. Method. Rats with carbon tetrachloride- (CCl4-) induced liver injury were treated with 100 mg/kg PC once daily for 21 days. The effects of PC therapy on (i) liver function and portal pressure, (ii) intestinal and hepatic histology, and (iii) plasma endotoxin, diamine oxidase (DAO), and tumour necrosis factor- (TNF-) α levels were investigated. Results. PC therapy reduced portal pressure and improved the liver function in CCl4-induced liver injury. In PC-treated liver injury rats, collagen fibres were gradually decreased, while the disordered arrangement of hepatocytes and disorganized hepatic lobules were partially repaired, and inflammatory cell infiltration was decreased in the fibrous tissue. Lower inflammatory cell infiltration in the ileum improved intestinal histology, and reduced serum DAO levels were observed in PC-treated cirrhotic rats. These changes were associated with reduced inflammatory activity, as indicated by decreased serum TNF-α levels and plasma endotoxin levels. Conclusions. These results suggest that PC therapy is hepatoprotective and is able to restore IBF and reduce endotoxaemia in rats with drug-induced liver injury.
format Article
id doaj-art-ee168ad890434ad69cfa730962ec1a45
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-ee168ad890434ad69cfa730962ec1a452025-02-03T00:59:15ZengWileyGastroenterology Research and Practice1687-61211687-630X2019-01-01201910.1155/2019/87234608723460Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in RatsMeijuan Chen0Haijun Huang1Pengcheng Zhou2Jiajie Zhang3Yining Dai4Danhong Yang5Xuegong Fan6Hongying Pan7Department of Infectious Disease, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, ChinaDepartment of Infectious Disease, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, ChinaInfection Control Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, ChinaDepartment of Infectious Disease, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, ChinaDepartment of Infectious Disease, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, ChinaDepartment of Infectious Disease, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, ChinaInfection Control Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, ChinaDepartment of Infectious Disease, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, ChinaObjective. Phosphatidylcholine (PC) is the major surface-active phospholipid and creates a hydrophobic nature to the surface. It has been reported to reverse the progression of liver fibrosis and to improve liver function. The aim of the present study was to evaluate the effects of orally administered PC on intestinal barrier function (IBF) in rats with drug-induced liver injury. Method. Rats with carbon tetrachloride- (CCl4-) induced liver injury were treated with 100 mg/kg PC once daily for 21 days. The effects of PC therapy on (i) liver function and portal pressure, (ii) intestinal and hepatic histology, and (iii) plasma endotoxin, diamine oxidase (DAO), and tumour necrosis factor- (TNF-) α levels were investigated. Results. PC therapy reduced portal pressure and improved the liver function in CCl4-induced liver injury. In PC-treated liver injury rats, collagen fibres were gradually decreased, while the disordered arrangement of hepatocytes and disorganized hepatic lobules were partially repaired, and inflammatory cell infiltration was decreased in the fibrous tissue. Lower inflammatory cell infiltration in the ileum improved intestinal histology, and reduced serum DAO levels were observed in PC-treated cirrhotic rats. These changes were associated with reduced inflammatory activity, as indicated by decreased serum TNF-α levels and plasma endotoxin levels. Conclusions. These results suggest that PC therapy is hepatoprotective and is able to restore IBF and reduce endotoxaemia in rats with drug-induced liver injury.http://dx.doi.org/10.1155/2019/8723460
spellingShingle Meijuan Chen
Haijun Huang
Pengcheng Zhou
Jiajie Zhang
Yining Dai
Danhong Yang
Xuegong Fan
Hongying Pan
Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats
Gastroenterology Research and Practice
title Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats
title_full Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats
title_fullStr Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats
title_full_unstemmed Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats
title_short Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats
title_sort oral phosphatidylcholine improves intestinal barrier function in drug induced liver injury in rats
url http://dx.doi.org/10.1155/2019/8723460
work_keys_str_mv AT meijuanchen oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats
AT haijunhuang oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats
AT pengchengzhou oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats
AT jiajiezhang oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats
AT yiningdai oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats
AT danhongyang oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats
AT xuegongfan oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats
AT hongyingpan oralphosphatidylcholineimprovesintestinalbarrierfunctionindruginducedliverinjuryinrats